India Glycols Limited — Investor Meet, 22-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

India Glycols reported strong Q4 & FY26. Full-year net revenue rose 11.8% to INR4,211 Cr, EBITDA 24.5% to INR654 Cr, and PAT 26.8% to INR293 Cr. Growth fueled by Potable Spirits (+14.4% revenue, IMFL rising) and Bio-Fuels (+40.9% revenue). Chemicals saw revenue decline but strong margin improvement. Management highlighted strategic shifts: premiumization in spirits, policy support for Bio-Fuels' 20% blending, and diversifying Ennature Biopharma with branded nutraceuticals. The company prepaid INR800 Cr debt, aiming for a debt-free Chemical business by FY28-29. Demerger order anticipated by early June. Management maintains an optimistic outlook on sustained growth and improved profitability.